HZNP
Closed
Horizon Pharma Plc
116.3
0.0 (0.00%)
Last Update: 09 Oct 2023 16:30:00
Yesterday: 116.3
Day's Range: 116.3 - 116.3
Send
sign up or login to leave a comment!
When Written:
109
Horizon Pharma PLC is a biopharmaceutical company that focuses on developing and commercializing medicines for rare and rheumatic diseases. The company was founded in 2005 and is headquartered in Dublin, Ireland, with additional offices in the United States and Europe.
Horizon Pharma's portfolio includes treatments for conditions such as gout, lupus, and thyroid eye disease. The company's flagship product is Krystexxa, a biologic drug used to treat severe gout. Other notable products include Rayos, a delayed-release corticosteroid, and Actimmune, an immune system stimulant.
In addition to its focus on rare diseases, Horizon Pharma also has a strong commitment to patient advocacy and support. The company offers a range of resources and services for patients and caregivers, including financial assistance programs and educational resources.
Horizon Pharma has been recognized for its innovation and growth, receiving awards such as the 2016 Company of the Year from the Irish Pharma Industry Awards and the 2015 Emerging Pharma Company of the Year from the Irish Times Business Awards.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Horizon Pharma's portfolio includes treatments for conditions such as gout, lupus, and thyroid eye disease. The company's flagship product is Krystexxa, a biologic drug used to treat severe gout. Other notable products include Rayos, a delayed-release corticosteroid, and Actimmune, an immune system stimulant.
In addition to its focus on rare diseases, Horizon Pharma also has a strong commitment to patient advocacy and support. The company offers a range of resources and services for patients and caregivers, including financial assistance programs and educational resources.
Horizon Pharma has been recognized for its innovation and growth, receiving awards such as the 2016 Company of the Year from the Irish Pharma Industry Awards and the 2015 Emerging Pharma Company of the Year from the Irish Times Business Awards.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








